These include Ras signaling, ErbB signaling, NSCLC, AML, pancreatic cancer, colorectal cancer, and renal cancer as a result of treatment resistance mechanisms from the BRAF/MEK/PI3K axis [10]. The gene discussed is MAP2K7; the disease is pancreatic neoplasm.